229 related articles for article (PubMed ID: 16857431)
1. Topoisomerase II and the etiology of chromosomal translocations.
Felix CA; Kolaris CP; Osheroff N
DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
[TBL] [Abstract][Full Text] [Related]
2. Leukemias related to treatment with DNA topoisomerase II inhibitors.
Felix CA
Med Pediatr Oncol; 2001 May; 36(5):525-35. PubMed ID: 11340607
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal translocations involving the MLL gene: molecular mechanisms.
Aplan PD
DNA Repair (Amst); 2006 Sep; 5(9-10):1265-72. PubMed ID: 16797254
[TBL] [Abstract][Full Text] [Related]
5. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
[TBL] [Abstract][Full Text] [Related]
6. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
7. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Lovett BD; Lo Nigro L; Rappaport EF; Blair IA; Osheroff N; Zheng N; Megonigal MD; Williams WR; Nowell PC; Felix CA
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9802-7. PubMed ID: 11493704
[TBL] [Abstract][Full Text] [Related]
8. ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Felix CA; Hosler MR; Winick NJ; Masterson M; Wilson AE; Lange BJ
Blood; 1995 Jun; 85(11):3250-6. PubMed ID: 7756657
[TBL] [Abstract][Full Text] [Related]
9. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute lymphoblastic leukaemia with MLL rearrangements following DNA topoisomerase II inhibitors, an increasing problem: report on two new cases and review of the literature since 1992.
Andersen MK; Christiansen DH; Jensen BA; Ernst P; Hauge G; Pedersen-Bjergaard J
Br J Haematol; 2001 Sep; 114(3):539-43. PubMed ID: 11552977
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal DNA topoisomerase II cleavage events at 5'-TATTA-3' sequences in MLL and AF-9 create homologous single-stranded overhangs that anneal to form der(11) and der(9) genomic breakpoint junctions in treatment-related AML without further processing.
Whitmarsh RJ; Saginario C; Zhuo Y; Hilgenfeld E; Rappaport EF; Megonigal MD; Carroll M; Liu M; Osheroff N; Cheung NK; Slater DJ; Ried T; Knutsen T; Blair IA; Felix CA
Oncogene; 2003 Nov; 22(52):8448-59. PubMed ID: 14627986
[TBL] [Abstract][Full Text] [Related]
12. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors.
Aplan PD; Chervinsky DS; Stanulla M; Burhans WC
Blood; 1996 Apr; 87(7):2649-58. PubMed ID: 8639880
[TBL] [Abstract][Full Text] [Related]
13. Chromatin structural elements and chromosomal translocations in leukemia.
Zhang Y; Rowley JD
DNA Repair (Amst); 2006 Sep; 5(9-10):1282-97. PubMed ID: 16893685
[TBL] [Abstract][Full Text] [Related]
14. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
[TBL] [Abstract][Full Text] [Related]
15. Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations.
Ahuja HG; Felix CA; Aplan PD
Genes Chromosomes Cancer; 2000 Oct; 29(2):96-105. PubMed ID: 10959088
[TBL] [Abstract][Full Text] [Related]
16. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
17. HRX gene rearrangement in secondary acute lymphoblastic leukemia.
Kobayashi Y; Hayashi Y; Ozawa K; Asano S
Leuk Lymphoma; 1995 May; 17(5-6):391-9. PubMed ID: 7549829
[TBL] [Abstract][Full Text] [Related]
18. Etoposide and illegitimate DNA double-strand break repair in the generation of MLL translocations: new insights and new questions.
Sung PA; Libura J; Richardson C
DNA Repair (Amst); 2006 Sep; 5(9-10):1109-18. PubMed ID: 16809075
[TBL] [Abstract][Full Text] [Related]
19. Bioflavonoids promote stable translocations between MLL-AF9 breakpoint cluster regions independent of normal chromosomal context: Model system to screen environmental risks.
Bariar B; Vestal CG; Deem B; Goodenow D; Ughetta M; Engledove RW; Sahyouni M; Richardson C
Environ Mol Mutagen; 2019 Mar; 60(2):154-167. PubMed ID: 30387535
[TBL] [Abstract][Full Text] [Related]
20. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites.
Felix CA; Lange BJ; Hosler MR; Fertala J; Bjornsti MA
Cancer Res; 1995 Oct; 55(19):4287-92. PubMed ID: 7671237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]